breast cancerThe St. Gallen (SG) International Breast Cancer Conference is held every two years, previously in St. Gallen and now in Vienna. This year (2023) marks the eighteenth edition of this conference, which focuses on the treatment of patients with early-stage breast carcinoma. A panel...
7. Breast Biopsies 8. Surgery Choices for Breast Cancer 9. Breast Reconstruction 10. Breast Cancer - Treatments & Side Effects 11. Survivorship After Treatment 12. Male Breast cancer 13. COVID-19 Impact on Breast Cancer 14. Gynecology 15. Obstetrician & Midwifery 16. Breast Cancer Prevention 1...
William J. Gradishar, MD, provides an overview of the current breast cancer treatment landscape, highlights updates to the NCCN guidelines from 2023 to 2024, and expresses optimism for addressing unmet needs at ASCO 2024. This is a modal window. The Playback API request failed for an ...
Breast Cancer Research and Treatment is a comprehensive forum dedicated to all aspects of breast cancer research. The journal's focus spans across various ...
March 2, 2023 By Lindsay Fischer Article Sarah Donahue, MPH, AOCNP, cochair of the 40th Annual Miami Breast Cancer Conference nursing track, discusses the biggest updates in breast cancer from 2022. Sarah Donahue, MPH, AOCNP Updated survival data from the DESTINY-Breast03 t...
[4] S. Modi, W. Jacot, 376O - Trastuzumab deruxtecan (T-DXd) versus treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Updated survival resu...
2. Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 3. Manohar P, et al. Updates in endocrine therapy for metastatic breast cancer. Cancer Biol Med. 20...
P ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNOTE-756 & BEGONIA" By Insights from 2023 ESMO Annual Meeting FEATURING Paolo Tarantino November 3, 2023 Comments 2 Login to view comments. Click here to Login Featured Video 03:15 Lilly Medical Affairs Unmet Needs...
Cancer Survivors Who Experience Functional Limitations Have Doubled in Past 20 Years Erin Hunter, Assistant Editor June 9th 2023 There are 8 million cancer survivors who may have limitations in their daily functional ability. Read More Oncology Pharmacists Connect Meeting Promises Clinical Updates, Oppor...
Breast cancer, a highly fatal disease due to its tendency to metastasize, is the most prevalent form of malignant tumors among women worldwide. Numerous studies indicate that breast cancer exhibits a unique predilection for metastasis to specific organs